We employ a proactive approach to risk management, identifying potential hazards at every stage of the product lifecycle and implementing preventive measures. Through root cause analysis, failure mode effects analysis (FMEA), and corrective and preventive actions (CAPA), we continuously improve our quality assurance processes to mitigate risks and enhance product quality.Vecent is also committed to continuous improvement in all aspects of our operations. We regularly assess our quality systems through internal audits, external inspections, and performance reviews, ensuring that our processes evolve in line with industry advancements, regulatory changes, and customer needs. Vecent Lifesciences believes that quality assurance does not end at the point of distribution. We maintain a robust post-market surveillance system to monitor the safety and efficacy of our products once they reach the market. Our pharmacovigilance team works diligently to track adverse events, manage product recalls, and ensure that any feedback from healthcare professionals and patients is acted upon promptly. This commitment to post-market quality ensures that our medicines continue to provide optimal therapeutic benefit throughout their lifecycle. Our commitment to quality is reinforced by a highly skilled and knowledgeable workforce. Vecent Lifesciences invests in ongoing employee training programs to ensure that every team member—from R&D to production, from quality control to customer service—understands the importance of quality and complies with the latest standards and regulatory requirements. This culture of quality starts from the top and permeates through every level of the organization.